Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Feasibility study of treatable-traits algorithm-guided asthma medication adjustment
ACTRN12620000935932Phase 4Completed
- Sponsor
- Medical Research Institute of New Zealand
- Start
- Sep 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 2
01
Overview
Phase 4, open-label, single-arm trial of budesonide + formoterol, budesonide, prednisone and tiotropium in asthma, sponsored by Medical Research Institute of New Zealand. Primary endpoints: Recruitment rate, Acceptability of intervention and 1 more. Started Sep 2020; status: completed.
02
Drugs
budesonide + formoterolbudesonideprednisonetiotropium
03
Conditions
asthma
Beyond the preview
Go deeper on ACTRN12620000935932.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12620000935932.